Molecular biology of osteosarcoma

AM Czarnecka, K Synoradzki, W Firlej, E Bartnik… - Cancers, 2020 - mdpi.com
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …

A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance

AS Doghish, M Hegazy, A Ismail, HA El-Mahdy… - … -Research and Practice, 2023 - Elsevier
Osteosarcoma (OS) is one of the most common bone cancers that constantly affects
children, teenagers, and young adults. Numerous epigenetic elements, such as miRNAs …

Pathogenesis and current treatment of osteosarcoma: perspectives for future therapies

R Rathore, BA Van Tine - Journal of clinical medicine, 2021 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumor in children and young
adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin …

Novel insights into the interaction between N6‐methyladenosine methylation and noncoding RNAs in musculoskeletal disorders

J Han, H Kong, X Wang, X Zhang - Cell Proliferation, 2022 - Wiley Online Library
Background Musculoskeletal disorder (MSD) are a class of inflammatory and degener‐ative
diseases, but the precise molecular mechanisms are still poorly understood. Noncoding …

The YAP/TAZ pathway in osteogenesis and bone sarcoma pathogenesis

H Kovar, L Bierbaumer, B Radic-Sarikas - Cells, 2020 - mdpi.com
YAP and TAZ are intracellular messengers communicating multiple interacting extracellular
biophysical and biochemical cues to the transcription apparatus in the nucleus and back to …

Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma

ZX Chong, SK Yeap, WY Ho - Pharmacological Research, 2021 - Elsevier
Osteosarcoma is one of the most prevalent primary bone tumors with a high metastatic and
recurrence rate with poor prognosis. MiRNAs are short and non-coding RNAs that could …

DDRGK1 enhances osteosarcoma chemoresistance via inhibiting KEAP1‐mediated NRF2 ubiquitination

X Wang, T Zhou, X Yang, X Cao, G Jin… - Advanced …, 2023 - Wiley Online Library
Chemoresistance is the main obstacle in osteosarcoma (OS) treatment; however, the
underlying mechanism remains unclear. In this study, it is discovered that DDRGK domain …

Osteocytes and bone metastasis

MA Riquelme, ER Cardenas, JX Jiang - Frontiers in endocrinology, 2020 - frontiersin.org
Bone is the most frequent site of breast cancer and prostate cancer metastasis, and one of
the most common sites of metastasis for many solid tumors. Once cancer cells colonize in …

Osteosarcoma and metastasis associated bone degradation—A tale of osteoclast and malignant cell cooperativity

KS Nørregaard, HJ Jürgensen, H Gårdsvoll… - International Journal of …, 2021 - mdpi.com
Cancer-induced bone degradation is part of the pathological process associated with both
primary bone cancers, such as osteosarcoma, and bone metastases originating from, eg …

LncRNA MALAT1-related signaling pathways in osteosarcoma

M Farzaneh, S Najafi, O Anbiyaee, S Azizidoost… - Clinical and …, 2023 - Springer
Osteosarcoma (OS) is a common and malignant form of bone cancer, which affects children
and young adults. OS is identified by osteogenic differentiation and metastasis. However …